Treatment-resistant Schizophrenia
Treatment-resistant schizophrenia is a form of schizophrenia that does not improve with standard antipsychotic medications, leading to persistent symptoms that can significantly impact daily life.
Refractory Schizophrenia: NaBen® with Clozapine
We are studying whether NaBen®, a new medication, can help adults with refractory schizophrenia who still have symptoms despite treatment with clozapine. The trial will also assess the safety of this combination therapy.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you between 18 and 55 years old?
- Do you have a diagnosis of schizophrenia that has lasted for at least 2 years?
- Are you currently pregnant or breastfeeding?
- Are you taking any medications for schizophrenia that have changed in the last 3 months?
- Have you had any serious medical illnesses like kidney failure, liver failure, or heart failure?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
NaBen
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Centrum Medyczne Luxmed Sp. z o.o.
Department of Psychiatry
Lublin, Poland
Centrum Badań Klinicznych PI-House sp. z o.o.
Department of Psychiatry
Nowy Port, Poland
Przychodnia Lekarsko Psychologiczna Persona Baranowski Mazurek Lekarzy sp.p.
Department of Psychiatry
Wrocław, Poland
Sponsor: Syneurx International (Taiwan) Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.